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Redox potentialA triad of tyrosine residues (Y152–154) in the cytochrome c1 subunit (C1) of the Rhodobacter capsulatus
cytochrome bc1 complex (BC1) is ideally positioned to interact with cytochrome c2 (C2). Mutational analysis
of these three tyrosines showed that, of the three, Y154 is the most important, since its mutation to alanine
resulted in signiﬁcantly reduced levels, destabilization, and inactivation of BC1. A second-site revertant of this
mutant that regained photosynthetic capacity was found to have acquired two further mutations—A181T and
A200V. The Y152Q mutation did not change the spectral or electrochemical properties of C1, and showed
wild-type enzymatic C2 reduction rates, indicating that this mutation did not introduce major structural
changes in C1 nor affect overall activity. Mutations Y153Q and Y153A, on the other hand, clearly affect the
redox properties of C1 (e.g. by lowering the midpoint potential as much as 117 mV in Y153Q) and the activity
by 90% and 50%, respectively. A more conservative Y153F mutant on the other hand, behaves similarly to
wild-type. This underscores the importance of an aromatic residue at position Y153, presumably to maintain
close packing with P184, which modeling indicates is likely to stabilize the sixth heme ligand conformation.
© 2012 Elsevier B.V. All rights reserved.1. Introduction
Electron transfer processes are of indisputable importance in met-
abolic pathways in most living organisms. They are essential for pho-
tosynthesis and respiration, in which energy gained from capturing
light or oxidation of nutrients is used to generate ATP. Cytochrome
bc1 (BC1; also called the bc1 complex or ubiquinol-cytochrome c re-
ductase) and the analogous cytochrome b6f complex, are ubiquitous
membrane proteins found in mitochondria and chloroplasts of eu-
karyotes and the cytoplasmic membrane of many respiratory and
photosynthetic bacteria. BC1 serves two functions—to transfer elec-
trons from ubiquinol to the soluble electron carrier cytochrome c,
and to generate the proton gradient used to drive ATP synthesis.
Given its essential role, BC1 has been the prime target of many anti-
malarial and antifungal drugs as well as herbicides which are current-
ly widely used [1-4].ase or Rieske iron–sulfur pro-
ome c2; Δfbc, mutant contain-
al growth medium containing
source; MOPS, 3-(N-morpho-
t. of Chemistry and Biochemis-
20 621 5256; fax: +1 520 621
t).
rights reserved.Depending on the species, there is variation in the number of poly-
peptides in the BC1 complex in eukaryotes. However, nearly all BC1
complexes contain three redox proteins: a cytochrome b (B) which
contains two non-covalently bound b hemes (bL and bH), a Rieske
iron-sulfur protein that contains a [2Fe–2S] cluster and a cytochrome
c1 (C1), which contains one covalently bound heme. Bacterial species
have the simplest form of BC1, which consists of a dimer of the three
core proteins, and have been used as model systems to study electron
transport within BC1 and between BC1 and its electron acceptor (i.e.
soluble cytochrome c2 (C2), membrane-anchored C2 (Cy) or high-
potential iron-sulfur protein, HiPIP, in photosynthetic bacteria). Elec-
tron transport within the BC1 complex is currently best explained by
a Q-cycle mechanism [5,6]. Without going into detail, one electron is
transferred from quinol to the b-heme and the other electron to the
Rieske [2Fe–2S] cluster, and subsequently to the C1 heme. C1 pro-
vides the docking site for the soluble interaction partner (C2, HiPIP)
at the membrane–aqueous interface and becomes oxidized.
X-ray crystallographic data from eukaryotic and prokaryotic BC1
complexes have shown that the functional core of BC1 is a dimer,
where each monomer is built of the three subunits. While the b
hemes are positioned in the transmembrane region, the Rieske and
C1 subunits from each monomer are anchored to the membrane via
a single α-helical transmembrane tail at their N- and C-terminus re-
spectively. The globular domain of each subunit is hydrophilic and re-
sides at the membrane–periplasmic interface [7-12]. Crystallographic
studies with and without several bound inhibitors have revealed that
Fig. 2. Structural view of the C2–C1–Rieske interface of R. capsulatus BC1, showing the
position of the tyrosines (cyan) in the Y-triad. C2 is blue; C1 is yellow, orange and cyan;
Rieske protein is green. The extension on C1 as compared to C2 structure is shown in
orange and cyan. C1 heme is pink, C2 heme is blue and [2Fe2S] is yellow and orange
sticks.
812 J.A. Kyndt et al. / Biochimica et Biophysica Acta 1817 (2012) 811–818a long-range movement of the head domain of the Rieske subunit is
crucial for electron transfer from quinol to the C1 subunit [7,9,13-
15]. Since there is no direct interaction between C2 and the Rieske
subunit, C1 forms a pivotal connection between the BC1 complex
and its soluble electron transfer partners.
Both C2 and C1 belong to the class I c-type cytochromes based on
their electrochemical and structural properties. Rhodobacter capsula-
tus soluble C2 has been studied intensively by mutagenesis and
three dimensional structure analysis. During ligand binding studies,
a region of 14 amino acids (positions 89–102), containing the sixth
heme ligand (M95), was identiﬁed as a ‘hinge region’ that undergoes
rapid large scale motion in ferri-C2, which includes the transient
breaking of the Fe-methionyl sulfur bond [16]. The ﬂexibility of the
hinge is likely due to its location within a loop between helices.
R. capsulatus and Rhodobacter sphaeroides C1 have an analogous
loop between helices, residues ~136 to 201, containing the sixth
heme ligand M183. The presence of a disulﬁde bridge within the
loop stabilizes it [19] and may reduce the size of the ﬂexible region
as shown in the sequence alignment of Fig. 1. It should be noted that
such a structure-based alignment of C1 has never been published,
thus there are 9 insertions and deletions, three of which are quite
large, 10, 17, and 18 residues. Recent imidazole binding studies on
C1 within R. sphaeroides BC1 suggests the existence of a hinge simi-
lar to the C2 hinge, although the exact conﬁnes of the ﬂexible region
have not been fully deﬁned [17,18]. Structural alignment of R. capsu-
latus C2 and C1 shows that the loop in C1 (orange and cyan sections
in Fig. 2), is much larger than in C2. Mutation of both Cys residues to
Ala, and the resulting loss of the disulﬁde bridge, lowers the C1
redox potential (by >300 mV) and results in the loss of photosyn-
thetic growth [19].
Interestingly, the R. capsulatus loop contains three consecutive ty-
rosine residues (Y152–Y154) that are positioned near the interaction
site for the C1 reaction partners (Rieske and C2), although they are
not highly conserved in eukaryotic C1s. The presence of the 18-
residue insertion in the bacterial loop suggests that the dynamics in
this region may not be the same for the two groups of C1 and that res-
idues conserved in one group may not be retained in the other. Thus,
it may not be possible to generalize conclusions of a single study toFig. 1. Alignment of the C1s for which there are 3-dimensional structures: 1. Chicken, 2. Bov
the bacterial C1s have a large 18-residue insertion in the region of interest, loop 136–201, th
bridge, C144–C167 which helps to stabilize the loop, is conserved in R. sphaeroides, but not i
the mutated residues are green.the family as a whole. We have postulated, based on structural
modeling, that two of these residues, Y152 and Y153 could form a ty-
rosine bridge that is involved in propagating a conformational change
from Rieske, through C1 to C2 [20]. In the model, C1 Y152 is posi-
tioned adjacent to the Rieske [2Fe2S] cluster when the latter is in
the C1 interacting position, while Y153 is pointing towards the C2
heme. It is therefore plausible that the change in Rieske conformation
(from interacting with B to interacting with C1) can exert an effect on
the C2 binding via a push–pull mechanism through the C1 tyrosine
bridge. In addition, a potential H-bond was identiﬁed in the modeled
structures between C1 Y153 and C2 T15, which strengthens the hy-
pothesis that this residue could be involved in complex formation
during reduction [20]. Y154 is not oriented towards C2 or the Rieske
protein, however, it is conserved in all structures, from both prokary-
otic and eukaryotic origin, suggesting an important structural or func-
tional role.ine, 3. Yeast, 4. R. capsulatus, 5. R. sphaeroides. Numbering is for R. capsulatus. Note that
at contains the sixth heme ligand Met 183 and the tyrosine triad, 152–154. The disulﬁde
n the eukaryotic C1s. Helices are underlined. The sixth heme ligand is colored blue and
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overall enzymatic activity from the bacterial Rieske iron–sulfur pro-
tein to C2, we have prepared and characterized mutants at C1 posi-
tions Y152, Y153 and Y154.2. Materials and methods
2.1. Growth and cell harvest
R. sphaeroides Δfbc is a strain that has a deleted fbc operon (con-
taining the Rieske iron–sulfur protein, cyt b, and cyt c1) and was gen-
erously provided by Prof. A. Crofts. All R. sphaeroides Δfbc cultures
with R. capsulatus complemented BC1 complex were grown on
RCVB media with kanamycin and tetracycline antibiotics (to ﬁnal
concentrations of 25 μg/ml and 1.25 μg/ml respectively). All mutant
and wild-type R. capsulatus BC1 containing plasmids were trans-
formed into the R. sphaeroides Δfbc strain by conjugation. Trans-
formed R. sphaeroides Δfbc was grown aerobically in the dark
(~48 h) and a fresh inoculumwas switched to photosynthetic growth
under anaerobic conditions (2–3 days, until OD550~1.0). Cells were
harvested by centrifugation at 5000×g for 30 min, and washed once
with 50 mM MOPS (pH 7.0), 100 mM KCl and 25% glycerol. Resus-
pended cells (~1/100 of the initial culture volume) were stored at
−80 °C.2.2. Cloning
A DNA fragment (3950 bp) containing all three genes of the bc1 op-
eron (Rieske iron–sulfur protein, cyt b and cyt c1), was cloned from R.
capsulatus genomic DNA using PCR. A second round of PCR was per-
formed to incorporate HindIII and KpnI restriction sites. In addition,
the KpnI primer contained a Factor Xa cleavage site and a His-tag se-
quence, which during PCR is incorporated at the C-terminal end of C1.
This PCR resulted in a 3456 bp fragment that contains a 657 bp 5′ and
a 44 bp 3′ extension (factor Xa and His-tag) in addition to the three
genes of the operon, and has the original c1 stop codonomitted. Primers
for the second round were: ACCCAAGCTTGAAGATCCTGCTTCTGACCGC
(HindIIIRcapsF) and GGGGTACCTTAGTGATGGTGATGGTGGTGCCCGCG
CCCCTCAATGGCCTTGTGGCCCTTG (KpnIHisfXaRcapsR). Sequences com-
plementary to the genomic DNA are underlined. Easy-A polymerase
was used in both reactions and DNA fragments were puriﬁed from gels
using the QIAEXII gel puriﬁcation kit (Qiagen). The resulting HindIII–
KpnI fragment was cloned into the pCR-XL-TOPO vector (Invitrogen)
after puriﬁcation, resulting in TOPO (WTbc1His). DNA sequencing
showed the presence of all three genes, including the His-tag and
promoter region. To reclone the bc1 operon into pRK415, the TOPO
construct was ﬁrst digested with HindIII and KpnI overnight, after
which NcoI was added to digest the remaining TOPO fragment.With-
out the additional NcoI digest, the TOPO and His-bc1 fragment are
very similar in size and difﬁcult to separate on agarose gels. Digested
and puriﬁed bc1-His fragment was then ligated into predigested
pRK415. The resulting pRK415(bc1His) was transformed into the
R. sphaeroides Δfbc strain by conjugation with Escherichia coli S17-1
as described [21].2.3. Mutagenesis
The Quick change site-directed mutagenesis kit (Stratagene) was
utilized with changes to the manufacturers' protocol as described
[22]. Mutagenesis was performed on TOPO (WTbc1His), with 26–
28mer primers to create the desired mutation. After sequencing to
conﬁrm the mutation, the complete bc1 operon was recloned into
pRK415 as described above.2.4. Protein puriﬁcation
Puriﬁcation was as described in [23] with the following modiﬁca-
tions. Chromatophores were resuspended in buffer A (50 mM MOPS-
NaOH, pH 7.0, 100 mM KCl, 20% glycerol), to 2–4 mg protein/ml based
on a standard BCA assay (Pierce).MOPSwas fromResearch Products In-
ternational, Mt. Prospect, Illinois. Chromatophores (10–20 ml per prep)
were dilutedwith 0.3 volumes of Buffer B (50 mMMOPS-NaOH, pH 7.8,
100 mM NaCl, 1 mMMgSO4, and 20% glycerol) to which 1 mg dodecyl
maltoside (DM)/mg protein was added from a 10% (w/v) DM solution
(Anagrade, D310, >99% pure, Anatrace, Maumee, Ohio). This was incu-
bated with gentle shaking at 4 °C for ~90 min. The solubilized proteins
were loaded onto a Ni-NTA resin column (Qiagen) and the ﬂow-
through was passed over the column a second time to increase binding
efﬁciency. All puriﬁcations were performed at 4 °C and in the presence
of protease inhibitors (Calbiochem Protease inhibitor cocktail set V,
EDTA-free). The washing and elution of the column were described in
[23], with the difference that an additional wash step with buffer C
(50 mMMOPS-NaOH, pH 7.8, 100 mM NaCl, 1 mM MgSO4, 0.01% DM)
supplemented with 10 mM His was performed to remove additional
background absorbance. The BC1 eluted in buffer C supplemented
with 200 mM His and 15 μg/ml phosphatidyl choline (PC; Avanti
Polar-Lipids Inc.). Purity was checked by SDS-polyacrylamide gel
electrophoresis. The BC1 concentration of puriﬁed protein was de-
termined based on both the oxidized and reduced Soret peak absor-
bances (εox=375 mM−1 cm−1; εred=450 mM−1 cm−1) and the
average was used for the enzymatic assay. Pyridine hemochrome as-
says were performed as described [24].
2.5. Enzymatic assay
All solutions were rendered anaerobic by bubbling argon gas
through them for at least 30 min. Decylubiquinol (>97% purity,
Sigma-Aldrich) was prepared by reducing a 50 μl solution of 25 mM
decylubiquinone (in 1:1 ethylene glycol:ethanol) with ~1 mg of sodi-
um borohydride on ice in a stoppered vial. The residual borohydride
was neutralized with 2 μl 0.1 M HCl. The decylubiquinol was diluted
in an anaerobic buffer (50 mM Tris–HCl, 100 mM NaCl, pH 8.0) to
50 μM, and BC1 was added immediately to a ﬁnal concentration of 5
nM. An anaerobic solution of 100 μM horse cytochrome c was pre-
pared using the same pH 8.0 buffer. The BC1 solution was mixed
with oxidized cytochrome c (100 μM) using an RX1000 Rapid Kinetics
Spectrometer Accessory, and the absorbance was recorded using a
Cary 300 spectrophotometer (detection wavelength=549.5 nm) for
1 min, to determine the reduction of cytochrome c by BC1. All assays
were done in triplicate at two BC1 concentrations (10 and 15 nM
BC1). The initial slope (C reduction) was used to determine initial
rates. These rates were divided by the BC1 concentration to obtain
the enzymatic activities shown in Table 1.
2.6. Spectroelectrochemistry
Methods for spectroelectrochemical measurements utilized the
same instrumentation and the same type of reference electrode (Ag/
AgCl, Em=−205 mV vs. SHE) as described [25], and employed the
same spectroelectrochemical cell and electrochemical mediators as
used previously [26]. Protein solutions (~0.05 mM) for electrochemi-
cal studies were prepared as before [27] in 100 mM potassium phos-
phate buffer at pH 7.5 containing 15 electrochemical mediators and in
addition contained ~20% glycerol. As described in detail previously
[27] the ratio of oxidized to reduced forms of each redox species is di-
rectly related to the absorbances of the optical spectra via Beer's law
and so the change in absorbance (in this case the absorbance at 4 nm
intervals between 412 and 440 nm) with respect to applied potential
can be ﬁt to the Nernst equation (Eq. (1)) using the nonlinear-least-
Table 1
Overview of growth, spectral and catalytic properties of wild-type and mutants of R.
capsulatus BC1. PS = photosynthetic; catalytic activity is the average of three measure-
ments; + good growth,− no visible growth; n.d. = not determined. Speciﬁc activity is
a mean value of three experiments and is in nmol cyt c reduced per second per nmol
BC1. The redox potential of WT was reported by Osyczka et al. [19] and Iwaki et al. [38].
Bc1 variant PS growth Soret maximum
(nm)
Em (mV) Speciﬁc
activity
Wild type + 416 +320 19±3.1
Y152Q + 416 n.d. 17±1.2
Y153F + 416 +300±20 17±3.0
Y153A + 413 +205±4 9.9±1.2
Y153Q + 414 +203±4 1.9±1.0
Y154A − 410 n.d. n.d.
Y154A, A181T, A200V + 414 +238±4 4.0±0.3
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Eapp ¼ Em þ 2:303 RT=nFð Þlog10 Ox½ = Red½ ð Þ ð1Þ
where Eapp is the applied potential, Em is the midpoint potential deter-
mined from these data, and [Ox] and [Red] are the concentrations in
the Fe(III) and Fe(II) states, respectively. Thus, for BC1 with three
hemes contributing to the observed absorbances in the optical spec-
trum, for any applied potential Eapp the observed change in absor-
bance due to reduction ΔrA at any one wavelength can be written as;
ΔrA ¼
ΔrA
c
1þ e
Eapp−Ecm
RT=nF
 þ ΔrAbH
1þ e
Eapp−E
bH
m
RT=nF
 !þ ΔrAbL
1þ e
Eapp−E
bL
m
RT=nF
 ! ð2Þ
where ΔrAc is the total change in absorbance due to heme c reduction
(extinction coefﬁcient change upon reduction times the total heme c
concentration times the path-length, Δrεc[heme c]l), and ΔrAbH is the
total change in absorbance due to heme bH reduction, and ΔrAbL is the
total change in absorbance due to heme bL reduction. The midpoint
potentials Emc , EmbH, and EmbL are for hemes c, bH, and bL, respectively,
and n=1 for a 1 electron heme reduction.
2.7. Structural modeling
A structural model of Y153Q was created by SWISS-model (http://
swissmodel. expasy.org//SWISS-MODEL.html). A single template ﬁle
was used (PDB ID: 1ZRT), which is the structure ﬁle for R. capsulatus
BC1 with stigmatellin bound. The model was generated with ProMo-
dII and energy minimization of the model was performed with Gro-
mos96. In silico single point mutations in the R. capsulatus BC1
structure (1ZRT) were created in Pymol 0.99 and the builder module
was used to predict potential steric clashes.
3. Results
3.1. Mutant growth and spectral analysis
As shown previously, modeling using known structures suggested
that three C1 tyrosines are at the C1/C2 interface (Y152, Y153 and
Y154) (Fig. 2) [20]. Glutaminemutants of Y152 and Y153were created
to determine the effect of removing the aromatic residue, while main-
taining H-bonding capability. Alanine mutations at Y153 and Y154
were chosen to study the deletion of both the aromatic and potentialFig. 3. A. SDS-page gel for wild-type R. capsulatus BC1, puriﬁed using a TALON (Ni-NTA resin
capsulatus BC1. Spectra were taken in 50 mM MOPS (pH 7.8, 20% glycerol, 100 mM NaCl, 1
Samples were oxidized with ferricyanide and reduced with ascorbate and subsequently wit
red lines show ascorbate-reduced minus ferricyanide-oxidized spectra. Panel B: WT; panel
A200V) mutant.H-bonding, while a phenylalanine mutation at Y153 was designed to
test the presence of an aromatic residuewithout the H-bonding capac-
ity. No visible difference was observed in growth rate between wild-
type and the BC1 mutants except for the Y154A mutant cultures (see
Table 1). R. sphaeroides Δfbc supplemented with the pRK415(fbc
Y154A) plasmid showed no growth under photosynthetic conditions.
In one instance however, abnormal growth with a lag phase lasting
~2 months was observed. The plasmidwas extracted from this culture
and sequenced, revealing two unintended mutations. One was A181T
and the other was A200V. Mass spectrometric analysis conﬁrmed the
existence of all three mutations in the one protein.
After puriﬁcation, all of the BC1 mutants showed similar patterns
on Coomassie blue stained SDS-PAGE gels under denaturing condi-
tions. In-gel tryptic digests followed by mass spectrometric analysis
showed that the three bands on the gel corresponded to cytochrome
b, cytochrome c1 and Rieske protein. As observed previously, the SDS-
PAGE gel pattern for cytochrome b could only be observed if the sam-
ple was not boiled before loading (Fig. 3A). The pyridine hemochro-
mogen assay [24] yielded the same b to c heme ratios for the
mutants and wild-type, consistent with both cytochrome c and b
being fully reconstituted in all mutants although the peaks were not
resolved nor quantiﬁed.
Using ascorbate reduced minus ferricyanide oxidized difference
spectra, we found the Y152Q and Y153F BC1 mutants having similar
levels of high potential C1 alpha peaks as wild-type (compare
Fig. 3B, C and F) as well as Soret wavelength maxima in dithionite
minus air oxidized spectra (Table 1). In contrast, the Y153A and
Y153Q mutants had blue-shifted Soret wavelength maxima (to 413
and 414 respectively, versus 416 nm for WT; see Table 1) and showed
signiﬁcantly less C1 reduction by ascorbate (by ca 0.5 and 0.75 respec-
tively, compare Fig. 3B, D and E), in spite of having wild-type amounts
of c-type heme based on pyridine hemochrome spectra. Wild-type
and all fourmutants had similar dithionite reducedminus ferricyanide
difference spectra in the b-type cytochrome alpha peak region
(~560 nm), but Y153A and Q mutants had signiﬁcantly smaller alpha
peaks in the 550 nm region characteristic of low-spin c-type cyto-
chrome. By inference, the reduced amount of alpha peak absorbance
with ascorbate and no additional amount with dithionite suggests
that the remainder of the heme is high spin. Dithionite minus ascor-
bate difference spectra for wild type BC1 and Y153F are consistent
with little or no c-type heme that is not ascorbate reducible, as
expected (supplemental information Fig. S1). Difference spectra for
mutants Y153Q and Y153A showed a similar pattern and indicate
that only a minor fraction of the C1 reduced further with dithionite
than what had already been reduced with ascorbate (Fig. S1). To sum-
marize in terms of spectral properties, Y152Q and Y153F appear to be
essentially identical to wild-type. However, the c-heme of Y153A and
Q is only partially reducible, by either ascorbate or dithionite. This sug-
gests a mixture of conformations, most likely resulting from the pres-
ence of both low- and high-spin c-type hemes corresponding to
protein with and without an attached sixth ligand.
Mutation of the most conserved residue in the Y-triad, Y154, to A
resulted in very low production of BC1 and only small amounts
could be isolated from aerobically grown cultures which rapidly de-
graded during puriﬁcation. The low yield and instability prevented
complete puriﬁcation of this mutant, but spectra indicated a blue-
shifted Soret peak of about 410 nm due to misfolding (Table 1). On
the other hand, the spontaneous second-site revertant mutant
(Y154A, A181T, A200V) resulted in sufﬁcient puriﬁed protein to ob-
tain useful data. When compared to wild-type spectra, the triple) afﬁnity column (M = marker). B–G. Reduced minus oxidized difference spectra of R.
mM MgCl2, 0.01% DM and 15 μg/ml PC). Figures B–G are taken in the α–β peak region.
h dithionite. Black traces show dithionite-reduced minus ferricyanide-oxidized spectra,
C: Y152Q; panel D: Y153A; panel E: Y153Q; panel F: Y153F; panel G: (Y154A, A181T,
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(Fig. 3G). The Soret peak in this mutant was less blue-shifted than in
the Y154A single mutant, but similar to the Y153A and Q mutants. In
addition, the dithionite minus ascorbate difference spectrum is also
similar to wild-type (Fig. S1).
3.2. Midpoint potentials
To further characterize the mutants, we performed spectroelectro-
chemical titrations. Upon titration of BC1 from+255 to +115 mV vs.
SHE, we mainly observed c heme reduction with the beginning of b
heme reduction, and over the range of +155 to −15 mV vs. SHE
we observed the start of b heme reduction. Titration data are given
in supplemental ﬁgures (S2A–D). From these titrations we were
able to determine the heme midpoint potentials as described in the
methods section (Table 1). The potential titration range chosen was
optimal for accurate determination of the c heme midpoint potentials
and typically covered sufﬁcient reduction of the b hemes to allow
deconvolution of the c heme absorbances from the b hemes using
Eq. (2). Typical midpoint potentials for cytochrome b were about
−77 mV for heme bL and +44 mV (vs. SHE) for heme bH, which
agree reasonably well with previously reported values for WT BC1
[28]. For the c heme, the potential of Y153F was similar to the
reported WT value and should be taken as the point of reference for
the other mutants. The derived midpoint potential for Y153Q was
+203 mV (vs. SHE). This value is about 97 mV lower than Y153F
and 117 mV lower than the reported WT value of +320 mV [19].
Y153A had the same c heme midpoint potential (+205 mV vs. SHE)
as Y153Q, and the triple mutant had a slightly higher midpoint poten-
tial of +238 mV (about 62 mV lower than Y153F).
3.3. Catalytic analysis
The catalysis of the oxidation of decylubiquinol and reduction of
horse cytochrome c by BC1 was used to determine enzymatic activity
[29]. Horse C and R. capsulatus C2 have similar tertiary structures and
the kinetic values for reduction by R. capsulatus BC1 are nearly iden-
tical [29]. Since horse C is more readily available, it was used in Rho-
dobacter BC1 activity assays. The results are provided in Table 1. The
wild-type activity was in the range of that published for R. capsulatus
and R. sphaeroides His-tagged puriﬁed BC1 [30]. Moreover, the Y152Q
and Y153F activities were identical to wild-type BC1 within experi-
mental error, which implies that these mutations do not change the
structure or electrochemistry of C1 to a degree that affects the func-
tion of the BC1. This also implies that the His tag has a minimal effect
on activity although this was not explicitly tested. However, the
Y153Q mutation signiﬁcantly lowered the enzymatic activity of
BC1 by ten-fold and the Y153A mutation lowered it two-fold. We
were unable to obtain sufﬁcient material for the Y154A mutant to
measure C2 reduction, however, the (Y154A, A181T, A200V) triple
mutant showed about a ﬁve-fold reduction in speciﬁc activity
(Table 1).
4. Discussion
Modeling of the R. capsulatus BC1 structure with the Rieske pro-
tein complexed with C1 or with B and subsequent docking with C2,
led us to propose that a triad of tyrosine residues in C1 (Y152–
Y154) could play a role in mediating binding and electron ﬂow from
the Rieske protein to the C2 [20]. Y152 points directly towards the
Rieske protein and is in close proximity to the iron–sulfur center in
the C1 bound position (Fig. 2). Y153 is oriented towards C2, it is sol-
vent exposed and, at least in the docking experiments, is within H-
bonding distance of the C2 T15 hydroxyl. However, Y153 is not con-
served in yeast BC1, and the structure of the yeast BC1/C complex
with bound yeast C shows that the main interactions stabilizing thecomplex are non-polar in nature and only two direct polar interac-
tions are present in the binding domain [8,12]. Y154 is not oriented
towards C2 or the Rieske protein, however, it is the most conserved
of the three tyrosines amongst different species and may therefore
play an essential structural role.
As reported here, mutation of residue Y152 to Q has little or no ef-
fect on the electrochemical properties or on the enzymatic activity of
BC1. This is consistent with the ﬁnding that a C1 Y152R mutation
allowed for normal photosynthetic growth of R. capsulatus [19]. The
fact that, in the modeled R. capsulatus structure, where the Rieske
protein is bound to C1, Y152 is positioned close to both the C1
heme and the Rieske 2Fe2S cluster, raised the possibility that the ar-
omatic ring could be indirectly involved in electron transfer between
the two cofactors [20]. As far we can tell, there is no evidence in our
assays that this electron transfer has been signiﬁcantly impaired by
the loss of the aromatic residue at position Y152.
It was proposed previously, based on the bovine BC1 crystal struc-
ture, that electron transfer from the Rieske 2Fe2S cluster occurs
through the bovine Rieske residue His 161 [31]. This residue forms a
hydrogen bond with one of the propionates of heme C1 when Rieske
is in the C position. The corresponding His residue (156) is conserved
in Rhodobacter BC1 and we therefore speculate it might have the
same role.
Mutation of C1 Y153 did result in a BC1 with very distinct proper-
ties compared to wild-type. Mutation of Y153 to Q resulted in a spec-
trally different BC1, where the intensities of the C1 α and β peaks
were signiﬁcantly lower than in wild-type C1 upon reduction. To a
lesser degree, this was also observed in the Y153A mutant. Measuring
the redox midpoint potential (Em) for Y153Q showed that the Em was
lowered to 203 mV for the C1 heme, while the cyt b heme values were
similar to WT. Although this is a signiﬁcant difference in redox poten-
tial for C1, it is not sufﬁcient to explain the lower magnitude of α and
β peaks upon reduction, since it is still considerably more positive
than the ascorbate redox potential of +60 mV (at pH 7). The results
rather suggest that the remaining heme is high spin. The fact that
we observe a small blue-shift in the Soret region with Y153A and
Y153Q, is consistent with the possibility that a certain amount of
high-spin C1 is present in these mutants, besides the lower potential
C1 population.
Very similar results were obtained with mutations made at posi-
tion F138 to non-aromatic amino acids [32]. Additional experiments
with those mutants showed that besides signiﬁcantly lower Em values
and lower magnitude of α and β peaks upon reduction, these mutants
also displayed altered EPR spectra. Therefore, in both the Y153 and
F138 mutants, redox and spin-state heterogeneity are likely to be
the cause of the observed spectral differences. F138 is structurally
just as close to the C1 hinge region as Y153, although it is oriented in-
wards as opposed to Y153 which points out towards C2. Nevertheless,
the close proximity of both residues to the hinge region, which con-
tains the sixth heme ligand, lead us to believe that both residues are
involved in structural stabilization of the hinge region to maintain op-
timal spectral and catalytic properties.
When examining one of the structures in the C1 hinge region, it
can be seen that Y153 is closely packed against the proline residue
(P184) that is next to the sixth heme ligand (M183) (Fig. 4). The closest
carbon atoms of the Y153 and P184 rings are only 3.6 Å´ apart and the
planes of the rings are almost parallel to each other. This suggests
a stabilizing packing between the two side chains. Such packing of
aromatic residues against the proline ring has been observed and
studied before in other proteins and is often found in type VI reverse
turns when the aromatic residue and the proline residue are posi-
tioned sequentially [33,34]. Thermodynamic calculations and com-
puter simulations of Tyr-Pro interactions in isolated peptides have
shown that the interaction is relatively strong and provide high sta-
bility to the folded peptide [35,36]. We therefore believe that the
Y153-P184 ring packing in C1 is important to provide stability to
Fig. 4. Detailed structural view of the C1 heme and hinge region. Hinge region is shown
in brown, Y-triad in cyan and C1 heme in pink. Y153 is packed closely to P184, which is
adjacent to the sixth heme ligand M183. Distances between carbon atoms (in Å´) are la-
beled in black.
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interaction.
The Y153–P184 interaction is consistent with the fact that the
spectra and Em values we obtained with the Y153F mutant are similar
to wild-type BC1. In this mutant, the aromatic-Pro packing is still
expected to occur, and no perturbation of the C1 heme region is
expected. By packing with P184, Y153 is bent in an almost cis confor-
mation. When a structural model was created in silico for the BC1
complex with the C1 Y153Q mutant, it became clear that a simple,
backbone-independent, replacement of Y with Q at that position cre-
ates steric clashes between Q153 and residues of the hinge region,
which would result in some backbone adjustment. Mutation of
Y153 to A does not create the observed steric clashes in our model,
however it will create an increased mobility in the hinge region, by
removal of the supporting aromatic/proline interaction. This is not
expected to be as detrimental as the Q mutation, which is reﬂected
in the slightly less-pronounced spectral changes we observed in the
Y153A mutant versus Y153Q.
In addition to the spectral changes, the Y153Q mutation also cre-
ated a 10-fold less catalytically efﬁcient BC1. The redox heterogeneity
of C1 (created by Y153 mutation), in which less reducible C1 is pre-
sent, could result in lower efﬁciency of overall C reduction, or the
structural interaction with C2 is impaired by removal of Y153, or a
combination of both. The following facts, however, argue against an
altered C2 interaction as the basis for the lower activity. First, the
Y153-T15 hydrogen bond in the docked R. capsulatus model could
still be achieved by Q (although it might be weakened and the
hinge region would have to move signiﬁcantly). However, the enzy-
matic activity is only reduced two-fold in Y153A versus ten-fold in
Y153Q, while the A mutation is clearly incapable of forming a H-
bond with C2 and therefore the activity would be expected to be
even lower than in the Y153Q mutant if an impaired C2 interaction
were the basis for the lower activity. Secondly, kinetics of C2 reduc-
tion with the Y153F mutant are essentially the same as wild-type,
which indicates that the aromatic properties of Y153 are more impor-
tant than potential H-bonding with C2. This is consistent with the
conclusion that the aromatic residue is necessary to maintain hinge
region stability and normal redox properties. We therefore conclude
that the lower activity is due to the redox heterogeneity of the Y153
mutants, which is linked to the structural perturbation of the hinge
region. The fact that Y153A has higher activity than Y153Q indicatesthat there is less structural perturbation in Y153A or that more mole-
cules can obtain the WT conformation at a given time.
Y154 is also part of the Y-triad and although it is not positioned for
interaction with any of the C1 interaction partners, it is the most con-
served tyrosine residue of the three. It is conserved in BC1 structures
from every species examined to date. To investigate whether this res-
idue has a structural function, we mutated it to an alanine residue.
Production yields and initial spectral analysis clearly indicate that,
upon removal of this residue, the BC1 is signiﬁcantly destabilized
andmost likely no longer functional in the cells, given the lack of pho-
tosynthetic growth of Rhodobacter Δfbc species complemented with
this BC1 mutant. This proves the structural necessity for this residue
at position 154 in R. capsulatus BC1 and, given its conserved nature,
also at equivalent positions in BC1 from other species. However,
slowly growing cultures were able to compensate for this loss of func-
tion by spontaneously introducing two additional mutations (A181T
and A200V). When the triple mutant protein was puriﬁed and charac-
terized, it displayed signiﬁcantly lower catalytic activity, reduction by
ascorbate, and lower Em (~62 mV lower than Y153F). Interestingly,
these two unintended mutations are on both sides of the region we
presumed to be the ‘hinge region’ of C1 based on homology with
the C2 hinge. It is intriguing that one of these mutations (A181T)
also spontaneously occurred upon deletion of the Cys144–Cys167
bridge that is part of the extended loop [19]. Upon introduction of
this mutation in wild type, a functional BC1 with lowered Em
(~100 mV lower than wild type) was created [37]. The latter behaved
very similarly to the triple mutant created in this study. Although the
exact function of these spontaneous mutations remains unknown, it
is plausible that they restore BC1 activity by stabilizing the hinge re-
gion and the position of the sixth ligand. Although activity was not
fully restored in the triple mutant, it appears to be sufﬁcient to pro-
duce a functional BC1 in growing cells.
Supplementary materials related to this article can be found on-
line at doi:10.1016/j.bbabio.2012.01.013.Acknowledgement
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